The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost
Noemia S. Lima(National Institutes of Health), Anna P. Wald, Lauren McCormick(National Institutes of Health), Satoshi Kamidani(Emory University), Christian Wake(National Institutes of Health), Srilatha Edupuganti(Emory University), Sarah Andrews(National Institutes of Health), Bob C. Lin(National Institutes of Health), Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute), Abby Spangler(National Institutes of Health), Paul C. Roberts(National Institutes of Health), Chaim A. Schramm(National Institutes of Health), Rebecca C. Brady(Cincinnati Children's Hospital Medical Center), Jennifer Husson(University of Maryland, Baltimore), Sonika Bhatnagar, Meagan E. Deming(University of Maryland, Baltimore), Kirsten E. Lyke(University of Maryland, Baltimore), Gysella Muñiz(University of Pittsburgh), Rahul Subramanian(National Institutes of Health), Christina A. Rostad(Emory University), Amy R. Henry(National Institutes of Health), Evan J. Anderson(Emory University), David Dobryzynski, HANA EL SAHLY, I‐Ting Teng(National Institutes of Health), J.P. Martin(Icahn School of Medicine at Mount Sinai), Samuel Li(Pfizer (United States)), Kumaravel Rajakumar(University of Pittsburgh), William L Catalano(National Institutes of Health), Tara M. Babu, Angie Price, Richard Rupp(The University of Texas Medical Branch at Galveston), Martín Bäcker(Island Hospital), Christine M. Posavad(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Daniel C. Douek(National Institutes of Health), Robert L. Atmar(Baylor College of Medicine), Peter D. Kwong(National Institutes of Health), Angela R. Branche(University of Rochester), Christine M. Johnston(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Mehul S. Suthar, 21-0012 Study Group, Adrian McDermott, Ann R. Falsey, Jennifer A. Whitaker, Ian Shannon, Sarah O’Connell, Angelica C. Kottkamp(NYU Langone Health), Yoav Pinto(National Institutes of Health), Wendy A. Keitel, Farida Laboune(National Institutes of Health)
Cited by 0
Related Papers
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
|New England Journal of Medicine|2015|3.4k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children
|New England Journal of Medicine|2015|1.9k
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
|Nature|2020|1.6k